TyRx Pharma, Inc. (TyRx Pharma) is a medical device company engaged in the development of medical devices and pharmaceutical products utilizing novel tyrosine-based resorbable systems. It develops Control of Implant Infection & Scarring product for Cardiovascular ,General Surgical and Cosmetic Surgical Implants. It is an ISO 9001:2000 and ISO 13485:2003 certified medical device manufacturer. The company is headquartered in New Jersey, United States.